Chungen Xing

585 citations
30 papers · 459 indexed · h-index 10
Topics
Cancer-related molecular mechanisms research (6 papers)MicroRNA in disease regulation (5 papers)Circular RNAs in diseases (5 papers)
Partner nations
China

In The Last Decade

Chungen Xing

28 papers receiving 457 citations

Peers

Chungen Xing
Comparison fields: 5 of 73
  • Molecular Biology 300
  • Cancer Research 274
  • Oncology 65
  • Epidemiology 65
  • Physiology 36
Replace Zhan Qu with:
Zhan Qu China
Peipei Nie China
Nidula Mullappilly Italy
Letizia Vallino Italy
Gouri Pandya India
Zhaowei Zou China
Xingmei Zhu China
Fang‐Wei Hu Taiwan
Chi‐Wei Chen Taiwan
Chungen Xing relative to Zhan Qu China Zhan Qu's profile →
Citations per field
00.5×
Zhan Qu · 1×
Citations per year

Countries citing papers authored by Chungen Xing

Since Specialization
Citations

This map shows the geographic impact of Chungen Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chungen Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chungen Xing more than expected).

Fields of papers citing papers by Chungen Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chungen Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chungen Xing. The network helps show where Chungen Xing may publish in the future.

Co-authorship network of co-authors of Chungen Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Chungen Xing. A scholar is included among the top collaborators of Chungen Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chungen Xing. Chungen Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 9
4 2
5 5
6 3
7 31
8 14
9 70
10 1
11 1
12 1
13 5
14 8
15 22
16 65
17 78
18 18
19
[Correlation of single nucleotide polymorphisms of X-ray repair cross complementing group 1 gene to hereditary susceptibility of colorectal cancer].
1
20 1

About Chungen Xing

Chungen Xing is a scholar working on Cancer Research, Business and International Management and Geriatrics and Gerontology, having authored 30 papers that have together received 459 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (274 citations), Geriatrics and Gerontology (21 citations) and Molecular Biology (300 citations). Chungen Xing has collaborated with scholars based in China. Frequent co-authors include Yongyou Wu, Kui Zhao, Wei Peng, Shuyu Zhang, Ming Li, Xiaohui Xu, Junjia Zhu, Xiaodong Yang, Yong Wu and Jianping Cao. Their work appears in journals such as Molecular and Cellular Biology, Oncotarget and Journal of Materials Chemistry B.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026